Head-To-Head Survey: Raia Drogasil (RADLY) versus Its Competitors

Raia Drogasil (OTCMKTS:RADLY) is one of 150 publicly-traded companies in the “Consumer Staples Distribution & Retail” industry, but how does it compare to its peers? We will compare Raia Drogasil to similar businesses based on the strength of its profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for Raia Drogasil and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Raia Drogasil	0	1	0	0	2.00
Raia Drogasil Competitors	2237	8232	10003	453	2.41

As a group, “Consumer Staples Distribution & Retail” companies have a potential upside of 59.90%. Given Raia Drogasil’s peers stronger consensus rating and higher possible upside, analysts plainly believe Raia Drogasil has less favorable growth aspects than its peers.

Insider & Institutional Ownership

45.0% of shares of all “Consumer Staples Distribution & Retail” companies are owned by institutional investors. 19.7% of shares of all “Consumer Staples Distribution & Retail” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Dividends

Raia Drogasil pays an annual dividend of $0.02 per share and has a dividend yield of 0.5%. Raia Drogasil pays out 13.3% of its earnings in the form of a dividend. As a group, “Consumer Staples Distribution & Retail” companies pay a dividend yield of 3.8% and pay out 36.7% of their earnings in the form of a dividend.

Profitability

This table compares Raia Drogasil and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Raia Drogasil	2.99%	20.12%	5.88%
Raia Drogasil Competitors	-25.67%	1.91%	2.62%

Valuation & Earnings

This table compares Raia Drogasil and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Raia Drogasil	$7.92 billion	$232.27 million	25.33
Raia Drogasil Competitors	$34.28 billion	$835.88 million	15.84

Raia Drogasil’s peers have higher revenue and earnings than Raia Drogasil. Raia Drogasil is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Raia Drogasil peers beat Raia Drogasil on 9 of the 14 factors compared.

Raia Drogasil Company Profile

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.